Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Celldex Therapeutics (CLDX) Asset Utilization Ratio (2016 - 2025)

Celldex Therapeutics (CLDX) has 15 years of Asset Utilization Ratio data on record, last reported at 0.0 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 71.13% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 71.13%, while the annual FY2025 figure was 0.0, 79.87% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per CLDX's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.04 in Q2 2021 and bottomed at 0.0 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.01 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 95.11% in 2022, then surged 439.49% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then crashed by 36.48% to 0.01 in 2022, then soared by 182.66% to 0.02 in 2023, then tumbled by 52.91% to 0.01 in 2024, then crashed by 71.13% to 0.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.01 in Q2 2025.